Y Intercept (Hong Kong) LTD Horizon Therapeutics Public LTD CO Transaction History

Y Intercept (Hong Kong) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $1.66 Million - $3.03 Million	-26,646 Reduced 93.58%	1,829 $208,000
Q2 2022 Aug 08, 2022	BUY	$79.4 - $116.36 $1.73 Million - $2.54 Million	21,824 Added 328.13%	28,475 $2.27 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $574,779 - $730,346	6,651 New	6,651 $700,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $494,574 - $601,708	-5,018 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $854,119 - $1.03 Million	-9,293 Reduced 64.94%	5,018 $550,000

Q2 2021 Aug 26, 2021	BUY	$86.24 - $95.92 $1.23 Million - $1.37 Million	14,311 New	14,311 $1.34 Million
Q2 2021 Aug 12, 2021	SELL	$86.24 - $95.92 $300,028 - $333,705	-3,479 Closed	0 $1.34 Million
Q1 2021 May 12, 2021	BUY	$71.83 - $95.48 $249,896 - $332,174	3,479 New	3,479 $303,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.